Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

The autoimmune disorder destroys the body's ability to produce insulin. Some patients in experimental trials have gotten it back.

Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary ...

Vertex, Inc. (NASDAQ:VERX) experienced a price target cut on November 5, 2025, with Goldman Sachs lowering its target from ...

Vertex (NASDAQ: VERX) delivered a split result this morning that left investors parsing mixed signals. The tax technology ...

For over a decade, mathematicians have failed to agree whether a 500-page proof is actually correct. Now, translating the ...

Tylah Tully looks at Vertex Minerals and its growing high-grade gold production in the latest episode of Stockhead's Who’s ...

Using visual and meaningful context aligned to how the brain learns can make math more understandable and engaging for all ...

Nebius Group N.V.'s strong Q3 earnings, major tech partnerships, and disciplined strategy drive growth and margins in the ...

If Vanderbilt finishes 10–2, the big question in the new twelve-team College Football Playoff isn’t “are they good enough?” ...